IJsselland Ziekenhuis

Verifiedinfo

The Netherlands Prins Constantijnweg 2, 2906 ZC Capelle Aan Den Ijssel, The Netherlands

11 trials recruiting
Colorectal cancer metastatic · Rectal cancer · Rheumatoid arthritis
Adults and children

About Specializations

IJsselland Ziekenhuis in Capelle Aan Den Ijssel, The Netherlands specialises in clinical trials of conditions such as Colorectal cancer metastatic, Rectal cancer, Rheumatoid arthritis, Colorectal cancer, and other specialisations. This site conducts important research.

Main research areas of the site

Oncology

The medical center is at the forefront of oncology research, focusing on innovative treatments and improving patient outcomes. The center's work in this field is particularly distinguished by its exploration of therapeutic interventions for colon cancer.

Colon Cancer Recurrence
Survival Rate Improvement
Post-Surgical Treatment Strategies

Through rigorous clinical trials, the center is advancing the understanding of how acetylsalicylic acid can impact long-term survival in patients with resected colon carcinoma, offering hope for enhanced therapeutic protocols.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location

Prins Constantijnweg 22906 ZC Capelle Aan Den IjsselThe Netherlands

Open in maps ↗

Recruiting now: 11 trials
Conditions studied: 23
Partner status: Verified

More sites in Capelle Aan Den Ijssel The Netherlands

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Quick filters

16 clinical trials

Triple negative breast cancer

Recruiting

Registered drugNo placebo

Study of pembrolizumab, capecitabine, or olaparib in patients with early-stage triple negative breast cancer and remaining disease after initial treatment

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Capecitabine
Sponsor:Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting

Contact Research Centre

Rectal cancer

Recruiting

Registered drugNo placebo

Study Comparing Surgery and Chemoradiotherapy with Capecitabine for Early Rectal Cancer Patients

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Capecitabine
Sponsor:Amsterdam UMC Stichting

Contact Research Centre

Appendicitis+4

Recruiting

Registered drugNo placebo

Study on Using Gentamicin and Clindamycin to Prevent Abscesses After Surgery for Complicated Appendicitis in Patients

Registered drugNo placebo

The Netherlands

Participants:0–17 years · 18–64 years · 65+ years
Substances:Clindamycin
Sponsor:Amsterdam UMC Stichting

Contact Research Centre

Rectal cancer

Recruiting

Registered drugNo placebo

Study on Preserving the Rectum in Early-Stage Rectal Cancer Patients Using Oxaliplatin and Capecitabine with Radiation Therapy

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Capecitabine
Sponsor:Stichting Radboud universitair medisch centrum

Contact Research Centre

Rheumatoid arthritis+1

Recruiting

Registered drugNo placebo

Study on Morning vs. Evening Dosing of Tofacitinib for Patients with Rheumatoid or Psoriatic Arthritis

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Tofacitinib
Sponsor:Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)

Contact Research Centre

Sepsis

Recruiting

Registered drugNo placebo

Study on Optimizing Initial Dosing of Flucloxacillin and Drug Combination for Critically Ill Patients with Sepsis in the ICU

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Amoxicillin
Sponsor:Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)

Contact Research Centre

Human papilloma virus immunisation+1

Recruiting

Registered drug

Study on HPV Vaccine for Women with Vulvar HSIL: Evaluating the Effectiveness of Nonavalent HPV Vaccine in Preventing Recurrence of Vulvar High-Grade Lesions

Registered drug

The Netherlands

Participants:18–64 years · 65+ years
Substances:Human Papillomavirus Type 11 L1 Protein - Adsorbed - In The Form Of Virus-Like Particles Produced In Yeast Cells (Saccharomyces Cerevisiae Canade 3C-5 (Strain 1895)) By Rdna
Sponsor:Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)